Riskpilot← Back to searchSign inGet full accessSynbiotics AB
ABActiveOrg 5565698965Varvstorget 16 Lgh 1302Research and experimental development on natural sciences and engineering · NACE 7210Est. 19990 employees
Revenue 2024
SEK 562K
0% vs 2023
EBITDA margin
-110.9%
+42% vs 2023
Equity ratio
31.8%
Financial strength
Net profit 2024
SEK 733K
+173% vs 2023
| Revenue | SEK 562K | +0% |
| EBITDA | SEK -624K | +42% |
| Net profit | SEK 733K | +173% |
| Total assets | SEK 30,8M | +5% |
| Equity | SEK 9,8M | +8% |
| Employees | 0 | — |
Legal name
Synbiotics AB
Org number
5565698965
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 maj 1999
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva forskning och utveckling av livsmedels- produkter, försäljning av hälsoprodukter och livsmedelsprodukter över internet samt därmed förenlig verksamhet.
Address
Varvstorget 16 Lgh 1302
Phone
+46705233200
Email
synbiotic2000@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 89 | 115 | 448 | 533 | 515 | 513 | 563 | 562 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −132 | −85 | −154 | −729 | −1 153 | −1 052 | −2 632 | −1 090 | −1 079 | −624 |
| Depreciation & amort. | −0 | −0 | −6 | −6 | −196 | −225 | −225 | −219 | −219 | −29 |
| EBIT | −132 | −85 | −160 | −735 | −1 349 | −1 277 | −2 857 | −1 309 | −1 298 | −652 |
| Net financials | 59 | 852 | 805 | −897 | 4 451 | 4 396 | 4 581 | 1 802 | 299 | 1 385 |
| Profit before tax | −72 | 766 | 644 | −1 147 | 3 809 | 3 118 | 1 725 | 628 | −999 | 733 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| Net profit | −72 | 766 | 644 | −1 147 | 3 809 | 3 118 | 1 725 | 628 | −999 | 733 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 1 675 | 2 528 | 15 748 | 27 145 | 29 370 | 34 677 | 33 882 | 29 362 | 30 768 |
| Equity | 0 | 1 280 | 1 924 | 777 | 4 586 | 7 704 | 9 429 | 10 057 | 9 058 | 9 791 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 246 | 19 916 |
| Short-term debt | 0 | 395 | 604 | 14 972 | 22 559 | 21 666 | 25 249 | 23 825 | 58 | 1 060 |
| Total debt | — | 395 | 604 | 14 972 | 22 559 | 21 666 | 25 249 | 23 825 | 20 304 | 20 977 |
EBITDA margin
-110.9%
This company
15.8%
Market median
-802% vs market
20152024
Equity ratio
31.8%
This company
38.2%
Market median
+17% vs market
20152024
Return on equity
7.5%
This company
18.4%
Market median
-59% vs market
20152024
Net profit margin
130.3%
This company
8.1%
Market median
+1509% vs market
20152024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20152024
Debt / equity
2.14×
This company
0.62×
Market median
-245% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LG Chief Auditor | Chief Auditor | 2021 | — | — |
KT | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Synbiotics AB 
Super Synbiotics ABBoard members of Synbiotics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Göran Michael Starck | Chief Auditor | 0 companies |
| Kurt Thomas Jägenstedt | Audit | 0 companies |
| Dan Samuel Bengmark | Deputy Board Member | 0 companies |
| Stig Bertil Samuel Bengmark | Board of Directors | 0 companies |
| Barbro Marianne Bengmark | Deputy Board Member | 0 companies |
| David Bengmark | Board of Directors | 0 companies |